A detailed history of Insight Inv LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Insight Inv LLC holds 1,702 shares of ABBV stock, worth $287,978. This represents 0.21% of its overall portfolio holdings.

Number of Shares
1,702
Previous 3,150 45.97%
Holding current value
$287,978
Previous $622,000 51.45%
% of portfolio
0.21%
Previous 0.53%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 21, 2025

SELL
$164.99 - $203.87 $238,905 - $295,203
-1,448 Reduced 45.97%
1,702 $302,000
Q2 2022

Aug 12, 2022

SELL
$137.62 - $174.96 $2,339 - $2,974
-17 Reduced 0.54%
3,150 $482,000
Q1 2022

May 10, 2022

SELL
$131.98 - $163.75 $52,791 - $65,500
-400 Reduced 11.21%
3,167 $513,000
Q4 2021

May 09, 2022

BUY
$107.43 - $135.93 $383,202 - $484,862
3,567 New
3,567 $483,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $299B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Insight Inv LLC Portfolio

Follow Insight Inv LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Insight Inv LLC, based on Form 13F filings with the SEC.

News

Stay updated on Insight Inv LLC with notifications on news.